Fix quality issues, the rest will fall in place Viveka Roychowdhury Feb 6, 2023 As policymakers strive to link budgetary allocations to better quality compliance, with stricter oversight?
FPME requests FM to continue Section 16 of IGST Act, 2017 without amendments Usha Sharma Feb 23, 2021 The provision gives two options to exporters, either to use LUT/Bond for removal of goods or services for export or pay IGST on…
Pharma sector reacts to Union Budget 2021 Usha Sharma Feb 1, 2021 Adopting the paperless culture, the Finance Minister Nirmala Sitharaman presented the Union Budget 2021-22 which is considered as…
Govt allots R&D grant of Rs 900 crores for COVID-19 vaccine development EP News Bureau Nov 12, 2020 The grant does not cover the cost of vaccine and distribution expenses
India to set up nuclear research reactor in PPP mode for medical isotopes EP News Bureau May 17, 2020 It will support affordable treatment for cancer and other diseases, said Finance Minister
‘Prices of key pharma ingredients could rise if coronavirus outbreak in China prolongs’ Press Trust of India Feb 19, 2020 China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates at $2,405.42 million to India in 2018-19
Budget 2020: What does the industry want? Usha Sharma Jan 16, 2020 Last year in July, Finance Minister Nirmala Sitharaman presented the first Budget of Modi Government 2.0. Since the pharmaceutical…
Time for a policy push for pharma Viveka Roychowdhury Jul 19, 2019 Delayed implementation of the API policy has resulted in India’s dependence on China
Will NDA-2’s first budget be any different for the pharma sector? Viveka Roychowdhury Jun 27, 2019 With actual fiscal outcomes for FY19 falling short of the revenue estimates put out in the interim budget, FM Sitharaman will have…
Nirmala Sitharaman urges Myanmar to collaborate with India in pharma Usha Sharma May 20, 2016 Highlighted that many CIS, LatAm countries have invited Indian collaborations for cost effective medicines for public health…